Quest Diagnostics [DGX] vs Idexx Laboratories [IDXX] Detailed Stock Comparison
Quest Diagnostics
NYSE
Loading...
Idexx Laboratories
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Quest Diagnostics wins in 9 metrics, Idexx Laboratories wins in 10 metrics, with 0 ties. Idexx Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Quest Diagnostics | Idexx Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.56 | 53.10 | Quest Diagnostics |
| Price-to-Book Ratio | 2.79 | 34.98 | Quest Diagnostics |
| Debt-to-Equity Ratio | 86.90 | 84.81 | Idexx Laboratories |
| PEG Ratio | 0.96 | 1.09 | Quest Diagnostics |
| EV/EBITDA | 12.77 | 37.41 | Quest Diagnostics |
| Profit Margin (TTM) | 9.03% | 24.41% | Idexx Laboratories |
| Operating Margin (TTM) | 15.10% | 33.62% | Idexx Laboratories |
| EBITDA Margin (TTM) | 15.10% | 33.62% | Idexx Laboratories |
| Return on Equity | 14.26% | 64.87% | Idexx Laboratories |
| Return on Assets (TTM) | 6.34% | 23.26% | Idexx Laboratories |
| Free Cash Flow (TTM) | $909.00M | $798.08M | Quest Diagnostics |
| 1-Year Return | 17.37% | 29.69% | Idexx Laboratories |
| Price-to-Sales Ratio (TTM) | 1.91 | 12.62 | Quest Diagnostics |
| Enterprise Value | $26.29B | $52.10B | Idexx Laboratories |
| EV/Revenue Ratio | 2.50 | 12.90 | Quest Diagnostics |
| Gross Profit Margin (TTM) | 34.15% | 62.62% | Idexx Laboratories |
| Revenue per Share (TTM) | $94 | $50 | Quest Diagnostics |
| Earnings per Share (Diluted) | $8.34 | $11.99 | Idexx Laboratories |
| Beta (Stock Volatility) | 0.46 | 1.50 | Quest Diagnostics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Quest Diagnostics vs Idexx Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Quest Diagnostics | -1.90% | 0.26% | 1.12% | 6.26% | 3.54% | 19.39% |
| Idexx Laboratories | 1.97% | -3.20% | 21.54% | 26.39% | 39.82% | 54.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Quest Diagnostics | 17.37% | 41.80% | 62.74% | 161.62% | 303.65% | 263.00% |
| Idexx Laboratories | 29.69% | 80.92% | 64.87% | 764.70% | 2,121.23% | 3,866.48% |
Performance & Financial Health Analysis: Quest Diagnostics vs Idexx Laboratories
| Metric | DGX | IDXX |
|---|---|---|
| Market Information | ||
| Market Cap | $20.10B | $50.94B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 787,620 | 544,207 |
| 90 Day Avg. Volume | 1,218,773 | 694,726 |
| Last Close | $180.23 | $645.55 |
| 52 Week Range | $146.17 - $185.62 | $356.14 - $688.12 |
| % from 52W High | -2.90% | -6.19% |
| All-Time High | $185.70 (Aug 22, 2025) | $706.95 (Jul 26, 2021) |
| % from All-Time High | -2.95% | -8.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.11% |
| Quarterly Earnings Growth | 0.23% | 0.45% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.24% |
| Operating Margin (TTM) | 0.15% | 0.34% |
| Return on Equity (TTM) | 0.14% | 0.65% |
| Debt to Equity (MRQ) | 86.90 | 84.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $64.54 | $18.20 |
| Cash per Share (MRQ) | $2.85 | $2.06 |
| Operating Cash Flow (TTM) | $1.68B | $905.81M |
| Levered Free Cash Flow (TTM) | $924.50M | $625.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Quest Diagnostics vs Idexx Laboratories
| Metric | DGX | IDXX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.56 | 53.10 |
| Forward P/E | 18.42 | 53.24 |
| PEG Ratio | 0.96 | 1.09 |
| Price to Sales (TTM) | 1.91 | 12.62 |
| Price to Book (MRQ) | 2.79 | 34.98 |
| Market Capitalization | ||
| Market Capitalization | $20.10B | $50.94B |
| Enterprise Value | $26.29B | $52.10B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.50 | 12.90 |
| Enterprise to EBITDA | 12.77 | 37.41 |
| Risk & Other Metrics | ||
| Beta | 0.46 | 1.50 |
| Book Value per Share (MRQ) | $64.54 | $18.20 |
Financial Statements Comparison: Quest Diagnostics vs Idexx Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DGX | IDXX |
|---|---|---|
| Revenue/Sales | $2.65B | $998.43M |
| Cost of Goods Sold | $1.79B | $375.05M |
| Gross Profit | $863.00M | $623.38M |
| Research & Development | N/A | $59.06M |
| Operating Income (EBIT) | $346.00M | $316.53M |
| EBITDA | $488.00M | $351.81M |
| Pre-Tax Income | $276.00M | $310.08M |
| Income Tax | $59.00M | $67.41M |
| Net Income (Profit) | $235.00M | $242.68M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DGX | IDXX |
|---|---|---|
| Cash & Equivalents | $188.00M | $163.97M |
| Total Current Assets | $2.08B | $1.32B |
| Total Current Liabilities | $1.44B | $1.14B |
| Long-Term Debt | $6.40B | $546.80M |
| Total Shareholders Equity | $7.04B | $1.45B |
| Retained Earnings | $9.49B | $5.58B |
| Property, Plant & Equipment | $2.75B | $833.62M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DGX | IDXX |
|---|---|---|
| Operating Cash Flow | $298.00M | $235.07M |
| Capital Expenditures | N/A | $-30.03M |
| Free Cash Flow | $197.00M | $207.94M |
| Debt Repayment | $-600.00M | N/A |
| Common Stock Repurchase | N/A | $-400.89M |
Short Interest & Institutional Ownership Analysis
| Metric | DGX | IDXX |
|---|---|---|
| Shares Short | 4.74M | 2.48M |
| Short Ratio | 3.60 | 4.68 |
| Short % of Float | 0.05% | 0.04% |
| Average Daily Volume (10 Day) | 787,620 | 544,207 |
| Average Daily Volume (90 Day) | 1,218,773 | 694,726 |
| Shares Outstanding | 110.62M | 81.60M |
| Float Shares | 111.23M | 79.12M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.00% | 0.98% |
Dividend Analysis & Yield Comparison: Quest Diagnostics vs Idexx Laboratories
| Metric | DGX | IDXX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |